OutSee has received an Innovate UK grant to conduct a pilot study utilizing agentic AI technology aimed at improving drug target validation processes. The initiative represents an effort to apply advanced artificial intelligence capabilities to enhance efficiency and accuracy in pharmaceutical research and development. Details regarding the specific scope and timeline of the pilot program were not disclosed in the announcement.
Search
